Mouillet, Guillaume http://orcid.org/0000-0002-2288-7461
Paillard, Marie-Justine
Maurina, Tristan
Vernerey, Dewi
Nguyen Tan Hon, Thierry
Almotlak, Hamadi
Stein, Ulrich
Calcagno, Fabien
Berthod, Diane
Robert, Elise
Meurisse, Aurelia
Thiery-Vuillemin, Antoine
Funding for this research was provided by:
Pfizer
Article History
Received: 17 January 2018
Accepted: 27 March 2018
First Online: 12 April 2018
Ethics approval and consent to participate
: The trial was reviewed and approved by the ethics committee of the University Hospital of Besançon and is registered with the Clinical Trials Registry (ClinicalTrials.gov identifier: NCT02689167). All participants will provide written informed consent in accordance with the Declaration of Helsinki. The review boards at all participating institutions will approve the study, which is conducted according to the Good Clinical Practice guidelines of the International Conference on Harmonisation.
: Not applicable
: Dr. Thiery-Vuillemin Antoine and Dr. Mouillet Guillaume received honoraria from Novartis, Pfizer, Roche, BMS, and Ipsen. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.